BROMOCRIPTINE (PARLODEL) IN THE TREATMENT OF PARKINSONS-DISEASE

被引：4
|
作者：
MOLINANEGRO, P
GRIMES, JD
JONES, MW
KOFMAN, OS
BOUCHARD, S
机构：
[1] SANDOZ, DEPT MED SERV, MONTREAL, QUEBEC, CANADA
[2] SHAUGHNESSY HOSP, VANCOUVER V6H 3N1, BC, CANADA
[3] OTTAWA CIVIC HOSP, OTTAWA K1Y 4E9, ONTARIO, CANADA
[4] MT SINAI HOSP, TORONTO M5G 1X5, ONTARIO, CANADA
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1982年 / 6卷 / 4-6期
关键词：
D O I：
10.1016/S0278-5846(82)80139-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：503 / 508
页数：6
相关论文
共 50 条
  • [41] COMPARISON OF EFFECTS OF BROMOCRIPTINE AND LEVODOPA IN PARKINSONS-DISEASE
    GODWINAUSTEN, RB
    SMITH, NJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (05): : 479 - 482
  • [42] USEFULNESS OF BROMOCRIPTINE IN ADVANCED FLUCTUATING PARKINSONS-DISEASE
    GRIMES, JD
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1979, 6 (03) : 396 - 396
  • [43] LONG-TERM RESULTS OF TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE AND DOMPERIDONE
    AGID, Y
    QUINN, N
    LHERMITTE, F
    REVUE NEUROLOGIQUE, 1981, 137 (01) : 49 - 51
  • [44] RETROPERITONEAL FIBROSIS AND TREATMENT OF PARKINSONS-DISEASE WITH HIGH-DOSES OF BROMOCRIPTINE
    DEMONET, JF
    ROSTIN, M
    DUEYMES, JM
    IOUALALEN, A
    MONTASTRUC, JL
    RASCOL, A
    CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) : 200 - 201
  • [45] BROMOCRIPTINE AS FIRST TREATMENT OF PARKINSONS-DISEASE - LONG-TERM RESULTS
    RASCOL, A
    MONTASTRUC, JL
    GUIRAUDCHAUMEIL, B
    CLANET, M
    REVUE NEUROLOGIQUE, 1982, 138 (05) : 401 - 408
  • [46] LOW-DOSE BROMOCRIPTINE ADDED TO LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE
    MASSETANI, R
    PICCINI, P
    MURRI, L
    MURATORIO, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (02): : 210 - 215
  • [47] EARLY TREATMENT WITH A COMBINATION OF BROMOCRIPTINE AND LEVODOPA COMPARED WITH LEVODOPA MONOTHERAPY IN THE TREATMENT OF PARKINSONS-DISEASE
    OLSSON, JE
    RASCOL, A
    KORTEN, JJ
    DUPONT, E
    GAUTHIER, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (05): : 1002 - 1014
  • [48] EARLY COMBINATION THERAPY WITH BROMOCRIPTINE AND LEVODOPA IN PARKINSONS-DISEASE
    FACTOR, SA
    WEINER, WJ
    MOVEMENT DISORDERS, 1993, 8 (03) : 257 - 262
  • [49] BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING-AGENT IN TREATMENT OF PARKINSONS-DISEASE
    AGID, Y
    BONNET, AM
    POLLAK, P
    SIGNORET, JL
    LHERMITTE, F
    LANCET, 1979, 1 (8116): : 570 - 572
  • [50] TREATMENT OF PARKINSONS-DISEASE WITH HIGH-DOSAGE BROMOCRIPTINE - POSSIBLE INTERACTION WITH JOSAMYCIN
    MONTASTRUC, JL
    RASCOL, A
    PRESSE MEDICALE, 1984, 13 (37): : 2267 - 2268
12345